Greenwood Village Psychiatrist Sentenced to Prison for Illegal Distribution of Controlled Substances and Financial Crimes
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Greenwood Village Psychiatrist Sentenced to Prison for Illegal Distribution of Controlled Substances and Financial Crimes

Greenwood Village Psychiatrist Sentenced to Prison for Illegal Distribution of Controlled Substances and Financial Crimes

June 09, 2023
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Steffan W. Tubbs
Phone Number: 571-387-5079

DENVER – Howard Weiss of Greenwood Village was sentenced to six months in federal prison for distributing a controlled substance outside the usual course of professional practice, for structuring financial transactions in a way to evade reporting requirements, and for engaging in monetary transactions greater than $10,000 that were derived from unlawful activity.  After his custodial sentence, the defendant will face ten months of home confinement, as part of three years on supervised release.  The 69-year-old also was ordered to forfeit $826,083.24 in criminal proceeds, pay $150,000 in community restitution, and surrender both his medical license as well his license to prescribe controlled substances. 

According to the plea agreement, the Drug Enforcement Administration (DEA) and the Internal Revenue Service (IRS-CI) began an investigation into the defendant because of suspicious financial activity, reports related to his patients’ sale of controlled substances, and one patient’s poly-drug overdose death. The investigation revealed that the defendant was prescribing methamphetamine to several adult patients. Methamphetamine is a Schedule II stimulant with a high potential for abuse. The FDA has approved only one methamphetamine product for medical use in rare circumstances. When investigators looked in detail at Weiss' prescribing records they discovered other red flags, including poly-drug prescribing. It is unusual to prescribe high-dose stimulants with high-dose sedatives because of the drugs competing effects. Yet, the defendant routinely prescribed high-dose stimulants with high-dose sedatives. The defendant also regularly prescribed stimulants such as Adderall at the upper end of the usual dosing range and, sometimes, well beyond the upper end of the usual dosing range.

In July 2017, one of the defendant’s patients was arrested when the patient showed up to a drug deal with 119 methamphetamine pills prescribed by the defendant. The defendant’s prescriptions to that patient were outside the usual course and did not have a legitimate medical purpose.  Further, the patient’s probation officer had previously contacted the defendant to warn about the patient’s methamphetamine addiction, but Weiss prescribed the methamphetamine anyway.

In addition, as described in the plea agreement, the defendant engaged in illegal banking activity.  Federal regulations prohibit the “structuring” of financial transactions to thwart the requirement that banks file reports for currency deposits of more than $10,000.  Between November 2015, and February 2018, the defendant made forty-five cash deposits in excess of $9,000 but below the $10,000 threshold, which would require the bank to file a Currency Transaction Report.  Bank tellers reported occasions in which the defendant would show up with cash, ask for it to be counted, and then decline to deposit any amount more than $10,000. 

“Howard Weiss knowingly and unlawfully distributed controlled substances outside the usual course of practice for no other purpose than greed,” said Acting Special Agent in Charge David S. Olesky.  “Thanks to the dedicated team at the DEA Rocky Mountain Field Division, the IRS-CI Denver Office and our U.S. Attorney’s Office, Weiss ended up losing more than he gained and will never lawfully practice medicine again.”

“IRS-CI Special Agents are experts in uncovering the financial schemes criminals use to hide money gained through illegal activities,” said Andy Tsui, Special Agent in Charge, Denver Field Office. “Weiss’ desire for money, and his disregard for the welfare of his patients, led to an investigation into his financial activity and ultimately the severe financial penalties that were handed down today.”

“This defendant prioritized personal enrichment over the health and safety of his patients,” said U.S. Attorney Cole Finegan.  “Thanks to the excellent investigation by our partners at DEA and IRS-CI, in addition to his prison sentence, the defendant will give up over $825,000 in criminal proceeds and will not be able to harm any more patients.”  

United States District Court Judge Daniel D. Domenico presided over the sentencing on June 6, 2023. 

Assistant United States Attorneys Bryan Fields and Jena Neuscheler are handling the prosecution. Assistant United States Attorney Elizabeth Young is handling the parallel forfeiture action.

Download Press Release
###
Methamphetamine
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

David S. Olesky Special Agent in Charge - Rocky Mountain
@DEAROCKYMTNDiv
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster